CDRT15
CMT1A duplicated region transcript 15 protein
Also known as: CDRTF_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96T59
- Gene
- CDRT15
- Ensembl
- ENSG00000223510
- Chromosome
- 17
- Canonical length
- 188 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
No narrative summary is available for CDRT15 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
188 residues, UniProt reviewed canonical sequence.
>Q96T59|CDRT15
1 MFSCCFPTSR GCCFRNGGSE SLFRRCRRRL IPHPRRLSPV VIRRIQVPQD SLGQALAGQA
61 TPEIPLGLQL HTVLVQEIQE LIEAQTLAPG PCAEVRALPA PAAEPEPAWE EAPPERALEL
121 EGAPAKDQTN EELPEITEVP ESIKRRLGRR VPAATPAPRG NLLLQAWMRV HSWASRLFAP
181 NVLPGTGPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDRT15 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- testis: 20 nTPM
- skin: 3.1 nTPM
- lymph node: 2.5 nTPM
- appendix: 1.1 nTPM
- spleen: 0.8 nTPM
- duodenum: 0.7 nTPM
Single-cell type
- late primary spermatocytes: 113 nCPM
- late spermatids: 77 nCPM
- early spermatids: 47 nCPM
- cardiomyocytes: 1.8 nCPM
- leydig cells: 0.3 nCPM
- peritubular myoid cells: 0.3 nCPM
Immune cell
- T-reg: 0.3 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebellum: 5.7 nTPM
- pons: 4.1 nTPM
- medulla oblongata: 3.9 nTPM
- cerebral cortex: 3.8 nTPM
- hippocampal formation: 3.4 nTPM
- thalamus: 3.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.89
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.57
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDRT15 as an antibody target. Whether an autoantibody or antibody against CDRT15 could matter depends on whether native CDRT15 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDRT15 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CDRT15 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...